Inovio Pharmaceuticals (INO) Non Operating Interest Expenses (2019 - 2024)
Inovio Pharmaceuticals (INO) recorded Non Operating Interest Expenses of $177,833 in FY2024, down 85.5% from $1.22 million in FY2023.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Non Operating Interest Expenses (2019 - 2024) Analysis & Trends
Starting with FY2017, Inovio Pharmaceuticals' Non Operating Interest Expenses history includes 7 years.
- Annual Non Operating Interest Expenses has declined for four straight years, with a five-year compound annual growth rate of -53.2% (FY2019 to FY2024).
- The FY2024 figure is the lowest annual Non Operating Interest Expenses since FY2017.
- Per Business Quant data, INO's Non Operating Interest Expenses was $1.22 million in FY2023 (-2.5%), $1.25 million in FY2022 (-35.2%), $1.94 million in FY2021 (-77.7%) and $8.7 million in FY2020 (+9.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Inovio Pharmaceuticals | 98.76 Mn | 98.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 177,833.00 |
| Dec 31, 2023 | 282,325.00 |
| Sep 30, 2023 | 313,488.00 |
| Jun 30, 2023 | 313,488.00 |
| Mar 31, 2023 | 313,488.00 |
| Dec 31, 2022 | 313,488.00 |
| Sep 30, 2022 | 313,488.00 |
| Jun 30, 2022 | 313,488.00 |
| Mar 31, 2022 | 313,488.00 |
| Dec 31, 2021 | 480,313.00 |
| Sep 30, 2021 | 476,374.00 |
| Jun 30, 2021 | 466,726.00 |
| Mar 31, 2021 | 513,034.00 |
| Dec 31, 2020 | 1.07 Mn |
| Sep 30, 2020 | 1.98 Mn |
| Jun 30, 2020 | 2.85 Mn |
| Mar 31, 2020 | 2.80 Mn |
| Dec 31, 2019 | 2.67 Mn |
| Sep 30, 2019 | 2.43 Mn |
| Jun 30, 2019 | 2.19 Mn |
API Access
Inovio Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();